iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 3,586 shares, an increase of 118.5% from the January 15th total of 1,641 shares. Based on an average daily trading volume, of 5,818 shares, the short-interest ratio is presently 0.6 days. Approximately 2.4% of the company’s stock are short sold. Approximately 2.4% of the company’s stock are short sold. Based on an average daily trading volume, of 5,818 shares, the short-interest ratio is presently 0.6 days.

iShares Neuroscience and Healthcare ETF Stock Performance

NYSEARCA:IBRN traded down $0.52 during midday trading on Thursday, reaching $31.68. 748 shares of the stock traded hands, compared to its average volume of 2,664. The stock has a market capitalization of $4.75 million, a PE ratio of 15.61 and a beta of 0.93. iShares Neuroscience and Healthcare ETF has a 12-month low of $17.86 and a 12-month high of $37.00. The business has a 50-day moving average of $32.36 and a two-hundred day moving average of $28.91.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.